Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Operating Expenses | 3,550 | 2,390 | 2,890 | 3,060 | 3,990 |
| Operating Income | -3,550 | -2,390 | -2,890 | -3,060 | -3,990 |
| Other Income | 1,200 | -1,120 | -40 | 2,200 | 2,240 |
| Pre-tax Income | -2,350 | -3,510 | -2,930 | -860 | -1,750 |
| Net Income Continuous | -2,345 | -3,513 | -2,932 | -863 | -1,743 |
| Net Income | $-2,345 | $-3,513 | $-2,932 | $-863 | $-1,743 |
| EPS Basic Total Ops | -1.44 | -3.00 | -3.84 | -1.56 | -67.95 |
| EPS Basic Continuous Ops | -1.44 | -3.02 | -3.86 | -1.58 | -67.82 |
| EPS Diluted Total Ops | -1.44 | -3.00 | -3.84 | -1.56 | -67.95 |
| EPS Diluted Continuous Ops | -1.44 | -3.02 | -3.86 | -1.58 | -67.82 |
| EBITDA(a) | $-3,610 | $-2,360 | $-2,850 | $-3,020 | $-3,950 |